Unit 1 Module 1 (Exam 1) Flashcards
New year, new semster, new challenges.
Ready?
Slide 7
What was the population of the United States in 2022?
A. 330 million
B. 331.1 million
C. 350 million
D. 310.2 million
B. 331.1 million
Slide 8
By 2030, what percentage of the U.S. population is projected to be over 65 years old?
A. 17%
B. 18%
C. 20%
D. 25%
C. 20% (one out of five people)
In 2022 only 17.5% were over the age of 65
Slie 8
Which factor contributes to IV access difficulties in elderly orthopedic patients? Select 2
A. Overhydration
B. Frail skin
C. Improved vein elasticity
D. Enhanced skin integrity
E. Movable veins
B. Frail skin
E. Movable veins
Slide 9
Why are thrombus risks increased in elderly patients undergoing orthopedic procedures?
A. Frequent physical activity
B. Active lifestyle
C. Hyperhydration
D. Sedentary lifestyle
D. Sedentary lifestyle
Slide 9
Common comorbidities in elderly orthopedic patients include ______ and ______.
A. Coronary artery disease, anemia
B. Diabetes, enhanced immunity
C. Arthritis, overhydration
D. Hypertension, improved bone density
A. Coronary artery disease, anemia
Slide 9
Preoperative assessments for elderly patients should include questions about ______ therapy.
A. Antibiotic
B. Anticoagulant
C. Vitamin
D. Pain management
B. Anticoagulant
Slide 9
Intraoperative positioning challenges in elderly patients are often due to ______ and ______.
A. Blood pressure, oxygenation issues
B. Enhanced mobility, vascular health
C. Muscle flexibility, hydration levels
D. Joint stiffness, bone fragility
D. Joint stiffness, bone fragility
slide 9
Which hormone increases in osteoporosis, contributing to bone density loss?
A. Growth hormone
B. Parathyroid hormone
C. Insulin-like growth factor
D. Estrogen
B. Parathyroid hormone
Slide 11
What are common causes of osteoporosis and fractures? (Select 2)
A. Decreased parathyroid hormone
B. Decreased growth hormone
C. Postmenopausal
D. Increased vitamin D levels
B. Decreased growth hormone
C. Postmenopausal
Slide 11
What factors contribute to decreased bone density in osteoporosis?
(Select 2)
A. Insulin-like growth factors
B. Decreased parathyroid hormone levels
C. Decreased vitamin D levels
D. Premenopausal
A. Insulin-like growth factors
C. Decreased vitamin D levels
Slide 11
Which bones are commonly fractured in patients with osteoporosis? (Select 3)
A. Proximal femur
B. Humerus
C. Skull
D. Wrist
E. Cervical Spine
A. Proximal femur
B. Humerus
D. Wrist
Slide 12
The thoracic and lumbar spine are prone to ______ fractures in patients with osteoporosis.
A. Stress
B. Compression
C. Spiral
D. Greenstick
B. Compression
Vertebral compression fractures in the spine are treated with a minimally invasive procedure called kyphoplasty
Stress fractures are tiny cracks in a bone. They’re caused by repetitive force, often from overuse — such as repeatedly jumping up and down or running long distances, usually happen in the lower legs or feet.
Slide 12
Which medication is NOT used to manage osteoporosis?
A. Fosamax
B. Actonel
C. Osteona
D. Reclast
E. Boniva
C. Osteona - completely made up name by me :)
Slide 12
Osteoarthritis is characterized by a loss of ______ cartilage, leading to inflammation.
A. Articular
B. Elastic
C. Compact
D. Spongy
A. Articular
“Bone on bone”
Slide 13
______% of patients over 65 with osteoarthritis experience physical limitations due to pain.
A. 5
B. 8
C. 10
D. 15
B. 8
Slide 13
What are common symptoms of osteoarthritis? (Select 3)
A. Pain
B. Crepitus
C. Increased joint strength
D. Decreased mobility
E. Improved circulation
A. Pain
B. Crepitus
D. Decreased mobility
Slide 14
What is crepitus in the context of osteoarthritis?
A. Tendons breaking
B. A type of bone fracture
C. Joint laxity
D. A scraping or popping sound
D. A scraping or popping sound
Either it’s between bone and cartilage or bone and bone
Slide 14
Which medications are used to manage osteoarthritis symptoms? (Select 3)
A. Fosamax
B. Celebrex
C. Opioids
D. NSAIDs
E. Antibiotics
B. Celebrex
C. Opioids
D. NSAIDs
Slide 14
Heberden nodes in osteoarthritis are characterized by swelling of the:
A. Proximal interphalangeal joints
B. Distal interphalangeal joints
C. Wrist joints
D. Metacarpophalangeal joints
B. Distal interphalangeal joints
Slide 15
Bouchard nodes are associated with swelling and spurring of the ______ interphalangeal joints.
A. Distal
B. Wrist
C. Metacarpophalangeal
D. Proximal
D. Proximal
Slide 15
Non-pharmacologic treatments for osteoarthritis include ______ and ______ therapy to improve mobility and reduce joint pain.
A. Massage, opioid
B. Hydrotherapy, steroid
C. Surgical, NSAIDs
D. Acupuncture, occupational
D. Acupuncture, occupational
Slide 16
______ therapy and ______ are non-pharmacologic strategies used to manage osteoarthritis symptoms.
A. Weight loss, TENS
B. Physical, corticosteroids
C. Massage, NSAIDs
D. TENS, opioids
A. Occupational, TENS
Slide 16
TENS stands for ______ Electro Nerve Stimulation.
A. Transcutaneous
B. Transient
C. Temporary
D. Transitional
A. Transcutaneous
Slide 16
Which NSAID is commonly prescribed for osteoarthritis?
A. Ibuprofen
B. Celecoxib
C. Meloxicam
D. Acetaminophen
C. Meloxicam
(Castillos mom takes it)
slide 17
What is a key concern with overuse of topical treatments like Voltaren?
A. They do not provide effective pain relief.
B. They can cause peptic ulcer disease and systemic side effects.
C. They are not absorbed into the body.
D. They promote cartilage regrowth.
B. They can cause peptic ulcer disease and systemic side effects.
Slide17
Celecoxib is classified as a:
A. COX-2 inhibitor
B. NSAID
C. Topical analgesic
D. Chondroprotective agent
A. COX-2 inhibitor
slide 17
Intra-articular therapy involves:
A. Oral NSAIDs
B. Topical treatments
C. Steroid injections
D. Acupuncture
C. Steroid injections
Can cause GI symptoms
slide 17
______ and ______ are examples of chondroprotective agents used in osteoarthritis management.
A. Glucosamine, chondroitin
B. Celecoxib, Voltaren
C. Meloxicam, acetaminophen
D. Ibuprofen, steroids
A. Glucosamine, chondroitin
Stop at least 2 weeks prior to surgery
Can also inculde Garlic, Ginko
Slide 17
Rheumatoid arthritis is primarily characterized as a:
Select 2
A. Chronic disesase
B. Acute with localized cartilage destruction
C. Temporary autoimmune condition
D. Chronic adipose disease
E. Systemic inflammatory disease
A.Chronic disease
D. Systemic inflammatory disease
Slide 18
In rheumatoid arthritis, connective and ______ tissue inflammation leads to ______.
A. Synovial, bone erosion
B. Connective, joint repair
C. Muscle, ligament repair
D. Cartilage, increased mobility
A. Synovial, bone erosion
Slide 18
______ and ______ are progressive outcomes of untreated rheumatoid arthritis.
A. Muscle regeneration, ligament repair
B. Bone erosion, enhanced mobility
C. Synovial thickening, improved flexibility
D. Cartilage destruction, impaired joint integrity
D. Cartilage destruction, impaired joint integrity
Slide 18
Rheumatoid arthritis commonly affects the ______ and ______ joints, causing pain and stiffness.
A. Wrists, metacarpophalangeal
B. Knees, shoulders
C. Distal interphalangeal, proximal interphalangeal
D. Spine, hip
A. Wrists, metacarpophalangeal
Slide 19
Rheumatoid nodules are typically found:
A. On muscle surfaces and on flexor surfaces
B. Only on distal interphalangeal joints
C. Around tendons in the spine
D. Surrounding joints and on extensor surfaces
D. Surrounding joints and on extensor surfaces
Slide 19
What is a distinguishing feature of subcutaneous rheumatoid nodules compared to Heberden and Bouchard nodes?
A. They are nonspecific and not limited to certain joints.
B. They are always found on the distal interphalangeal joints.
C. They are always proximal to the wrist.
D. They are associated with cartilage regrowth.
A. They are nonspecific and not limited to certain joints.
Slide 19
Systemic symptoms of rheumatoid arthritis include ______, ______, and weakness.
A. Weight gain, insomnia
B. Fatigue, anorexia
C. Joint swelling, cartilage growth
D. Increased mobility, strength
B. Fatigue, anorexia
Slide 19
______ and ______ are lab tests that help confirm the diagnosis of rheumatoid arthritis.
A. Rheumatoid factor, anti-immunoglobulin antibody
B. C-reactive protein, calcium
C. Erythrocyte sedimentation rate, glucose
D. Hematocrit, hemoglobin
A. Rheumatoid factor, anti-immunoglobulin antibody
Slide 20
______ and ______ are tests used to monitor systemic inflammation in rheumatoid arthritis patients.
A. Anti-immunoglobulin antibody, calcium
B. Rheumatoid factor, hemoglobin
C. Erythrocyte sedimentation rate, C-reactive protein
D. Platelet count, creatinine
C. Erythrocyte sedimentation rate, C-reactive protein
Slide 20